Lying‑Sitting‑Standing Baduanjin to improve heart and lung function in acute coronary syndrome with heart failure
A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin
This study will test whether a gentle sequence of Baduanjin exercises performed lying, sitting, and standing helps people hospitalized with acute coronary syndrome and heart failure improve heart and lung function and quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 65 (estimated) |
| Ages | N/A to 85 Years |
| Sex | All |
| Sponsor | Second Hospital of Shanxi Medical University Academic / other |
| Locations | 1 site (Taiyuan, Shanxi) |
| Trial ID | NCT07486791 on ClinicalTrials.gov |
What this trial studies
Participants with acute coronary syndrome complicated by heart failure will receive standard medical treatment and routine rehabilitation nursing guidance, with some patients also doing a sequential lying‑sitting‑standing Baduanjin exercise program. The intervention group will perform the Baduanjin sequence alongside usual care while the comparison group receives usual care alone. Cardiopulmonary function and quality of life will be measured using echocardiography, NT‑proBNP, 6‑minute walk test, NYHA class, and the SF‑36 questionnaire. Results will be compared to see if this low‑intensity exercise sequence can be a viable early cardiac rehabilitation option.
Who should consider this trial
Good fit: Ideal candidates are people hospitalized with ACS who develop heart failure, are age 85 or younger, have at least grade‑3 muscle strength, are conscious, and can provide informed consent.
Not a fit: Patients with persistent NYHA class IV symptoms despite optimal therapy, uncontrolled arrhythmias or hypertension, hemodynamic instability, untreated structural heart disease, or other acute severe illnesses are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If effective, this simple, low‑cost exercise sequence could improve cardiopulmonary function and quality of life and offer a practical early cardiac rehabilitation option for these patients.
How similar studies have performed: Previous smaller studies of Baduanjin and similar Qigong exercises have shown promise for cardiac rehabilitation outcomes, but the specific lying‑sitting‑standing sequential approach is relatively novel and less studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients meeting the diagnostic criteria for ACS (including unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction) * Complicated by heart failure during hospitalization * Age ≤ 85 years * Muscle strength ≥ grade 3 * No history of mental illness, conscious and able to cooperate independently with this study * Voluntarily participate in this study and sign the informed consent form Exclusion Criteria: * Patients with persistent heart failure symptoms or NYHA functional class IV despite optimal pharmacological therapy; * Patients with contraindications to cardiac rehabilitation, such as uncontrolled hypertension, uncontrolled arrhythmias, or hemodynamic instability; * Patients with untreated structural heart disease, such as heart failure caused by valvular heart disease or congenital heart disease; * Patients in the acute phase of various diseases, such as severe infection, deep vein thrombosis, or severe hepatic or renal failure; * Patients with disabilities, bone or joint diseases, or neurological disorders that preclude participation in Baduanjin exercises; * Patients with a life expectancy of less than one year; * Patients currently participating in other clinical trials.
Where this trial is running
Taiyuan, Shanxi
- Second Hospital of Shanxi Medical — Taiyuan, Shanxi, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.